Clinical Trial Update: A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 dose-confirmation study assessing safety, reactogenicity, and immunogenicity of the CVnCoV vaccine in healthy adults for COVID-19; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• CVnCoV (CVnCoV)

Snippet

Sponsor: CureVac | Conditions: Coronavirus, Covid19 | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28